ZeaVision, Inc.   Report issue

For profit Phase 4
Founded: Chesterfield MO United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2012
NCT02017418
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

ZeaVision, LLC